You‐Cheol Hwang

4.1k total citations · 1 hit paper
123 papers, 2.9k citations indexed

About

You‐Cheol Hwang is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, You‐Cheol Hwang has authored 123 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Endocrinology, Diabetes and Metabolism, 35 papers in Surgery and 32 papers in Epidemiology. Recurrent topics in You‐Cheol Hwang's work include Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers), Diabetes Treatment and Management (19 papers) and Liver Disease Diagnosis and Treatment (18 papers). You‐Cheol Hwang is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers), Diabetes Treatment and Management (19 papers) and Liver Disease Diagnosis and Treatment (18 papers). You‐Cheol Hwang collaborates with scholars based in South Korea, United States and United Kingdom. You‐Cheol Hwang's co-authors include Kyu Jeung Ahn, In‐Kyung Jeong, Ho Yeon Chung, Hong Yup Ahn, Cheol‐Young Park, Sang Youl Rhee, Jeong‐Taek Woo, Donna L. Leonetti, Edward J. Boyko and Wilfred Y. Fujimoto and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

You‐Cheol Hwang

119 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sarcopenia in youth

2023 76 citations You‐Cheol Hwang et al. Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
You‐Cheol Hwang South Korea	30	946	725	614	575	469	123	2.9k
Kwang Joon Kim South Korea	28	652 0.7×	360 0.5×	237 0.4×	560 1.0×	317 0.7×	99	2.1k
Dimitrios N. Kiortsis Greece	37	811 0.9×	617 0.9×	454 0.7×	727 1.3×	767 1.6×	98	3.2k
Peter Hovind Denmark	37	1.4k 1.5×	519 0.7×	579 0.9×	339 0.6×	573 1.2×	72	4.2k
Tanja B. Grammer Germany	36	845 0.9×	333 0.5×	563 0.9×	456 0.8×	936 2.0×	110	3.7k
Jutta Dierkes Norway	38	476 0.5×	858 1.2×	633 1.0×	340 0.6×	678 1.4×	158	4.1k
Kyu Jeung Ahn South Korea	25	687 0.7×	395 0.5×	542 0.9×	313 0.5×	313 0.7×	107	2.1k
Se Eun Park South Korea	32	1.4k 1.5×	692 1.0×	667 1.1×	1.3k 2.3×	546 1.2×	128	3.3k
Zipora Matas Israel	33	479 0.5×	527 0.7×	557 0.9×	685 1.2×	481 1.0×	68	3.3k
Leila R. Zelnick United States	26	838 0.9×	356 0.5×	417 0.7×	328 0.6×	422 0.9×	109	2.9k
Muhei Tanaka Japan	31	670 0.7×	733 1.0×	467 0.8×	516 0.9×	375 0.8×	106	2.7k

Countries citing papers authored by You‐Cheol Hwang

Since Specialization

Citations

This map shows the geographic impact of You‐Cheol Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by You‐Cheol Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites You‐Cheol Hwang more than expected).

Fields of papers citing papers by You‐Cheol Hwang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by You‐Cheol Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by You‐Cheol Hwang. The network helps show where You‐Cheol Hwang may publish in the future.

Co-authorship network of co-authors of You‐Cheol Hwang

This figure shows the co-authorship network connecting the top 25 collaborators of You‐Cheol Hwang. A scholar is included among the top collaborators of You‐Cheol Hwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with You‐Cheol Hwang. You‐Cheol Hwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hwang, You‐Cheol, et al.. (2025). Comparison of Efficacy and Safety of Cilostazol/Extract of Ginkgo biloba vs. Aspirin in Carotid Atherosclerosis in Patients with Diabetes Mellitus. Diabetes & Metabolism Journal. 50(2). 357–367.

Park, So Young, Ji Eun Jun, In‐Kyung Jeong, et al.. (2024). Comparison of the Efficacy of Ezetimibe Combination Therapy and High-Intensity Statin Monotherapy in Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 109(7). 1883–1890. 2 indexed citations

Jun, Ji Eun, et al.. (2024). Combination of low- or moderate-intensity statin and ezetimibe vs. high-intensity statin monotherapy on primary prevention of cardiovascular disease and all-cause death: a propensity-matched nationwide cohort study. European Journal of Preventive Cardiology. 31(10). 1205–1213. 5 indexed citations

Lee, Hojae, Myeongcheol Lee, Jaeyu Park, et al.. (2024). Prediction model for cardiovascular disease in patients with diabetes using machine learning derived and validated in two independent Korean cohorts. Scientific Reports. 14(1). 14966–14966. 12 indexed citations

Han, Kyung Ah, You‐Cheol Hwang, Shinje Moon, et al.. (2024). Dual add‐on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study. Diabetes Obesity and Metabolism. 26(9). 3743–3752. 1 indexed citations

Jun, Ji Eun, You‐Cheol Hwang, Kyu Jeung Ahn, et al.. (2022). The efficacy and safety of Dendropanax morbifera leaf extract on the metabolic syndrome: a 12-week, placebo controlled, double blind, and randomized controlled trial. Nutrition Research and Practice. 16(1). 60–60. 1 indexed citations

Jun, Ji Eun, Mira Kang, Sang‐Man Jin, et al.. (2021). Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification. European Journal of Endocrinology. 184(6). 867–877. 17 indexed citations

Yoo, Jin, In‐Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung, & You‐Cheol Hwang. (2021). Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy. Metabolism. 120. 154798–154798. 81 indexed citations

Jun, Ji Eun, Min Sun Choi, Sung Woon Park, et al.. (2021). Low Skeletal Muscle Mass Is Associated With the Presence, Incidence, and Progression of Coronary Artery Calcification. Canadian Journal of Cardiology. 37(9). 1480–1488. 15 indexed citations

10.

Park, Sung Woon, et al.. (2020). Validation of the effectiveness of a digital integrated healthcare platform utilizing an AI-based dietary management solution and a real-time continuous glucose monitoring system for diabetes management: a randomized controlled trial. BMC Medical Informatics and Decision Making. 20(1). 156–156. 14 indexed citations

11.

Kwak, Soo Heon, You‐Cheol Hwang, Jong Chul Won, et al.. (2019). Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open‐label, active‐controlled, 12‐week study (STABLE II study). Diabetes Obesity and Metabolism. 22(2). 173–181. 16 indexed citations

12.

Hwang, You‐Cheol, Hong Yup Ahn, Sung‐Woo Park, & Cheol‐Young Park. (2017). Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men. Clinical Gastroenterology and Hepatology. 16(7). 1131–1137.e5. 41 indexed citations

13.

Choung, Se‐Young, et al.. (2016). Aster spathulifolius Maxim extract reduces body weight and fat mass in obese humans. Nutrition Research. 36(7). 671–678. 14 indexed citations

14.

Hwang, You‐Cheol, Seung‐Hoi Koo, Kyong Soo Park, et al.. (2013). PPAR-γ Activation Increases Insulin Secretion through the Up-regulation of the Free Fatty Acid Receptor GPR40 in Pancreatic β-Cells. PLoS ONE. 8(1). e50128–e50128. 93 indexed citations

15.

Chin, Sang Ouk, Jin Kyung Hwang, Sang Youl Rhee, et al.. (2013). Risk Factors for the Progression of Intima-Media Thickness of Carotid Arteries: A 2-Year Follow-Up Study in Patients with Newly Diagnosed Type 2 Diabetes. Diabetes & Metabolism Journal. 37(5). 365–365. 7 indexed citations

16.

Chin, Sang Ouk, Sang Youl Rhee, Suk Chon, et al.. (2013). Investigation of Responsiveness to Thyrotropin-Releasing Hormone in Growth Hormone-Producing Pituitary Adenomas. International Journal of Endocrinology. 2013. 1–7. 2 indexed citations

17.

Hwang, You‐Cheol, Hong Yup Ahn, In‐Kyung Jeong, Kyu Jeung Ahn, & Ho Yeon Chung. (2012). Optimal Range of Triglyceride Values to Estimate Serum Low Density Lipoprotein Cholesterol Concentration in Korean Adults: the Korea National Health and Nutrition Examination Survey, 2009. Journal of Korean Medical Science. 27(12). 1530–1530. 10 indexed citations

18.

Kang, Jun Goo, et al.. (2012). Diabetes Educator Training Module (DETM). Journal of Korean Diabetes. 13(3). 162–162. 3 indexed citations

19.

Chon, Suk, Yun Jung Lee, You‐Cheol Hwang, et al.. (2011). Autoimmune Hypoglycemia in a Patient with Characterization of Insulin Receptor Autoantibodies. Diabetes & Metabolism Journal. 35(1). 80–80. 21 indexed citations

20.

Kim, Han‐Suk, Han Jo Kim, You‐Cheol Hwang, et al.. (2002). A case of Goodpasture syndrome with diffuse pulmonary hemorrhage.. The Korean Journal of Internal Medicine. 63(1). 85–91.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact